[1]
E. D. Briceño and A. L. Naranjo-Gomez, “Bevacizumab with adjuvant cyclophosphamide metronomical dose an alternative therapy in patients with recurrent gliomas”, Arch Neurocien, vol. 23, no. 3, pp. 19–27, May 2020.